RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and immunogenicity of an RSV-F protein
nanoparticle vaccine, with aluminum, in healthy third-trimester pregnant women and to assess
the impact of maternal immunization on infant safety through one year of life.